series-a
Stage
1
Investors
About
ALLOX develops an AI-enabled platform to systematically discover allosteric drug targets and accelerate the development of selective allosteric inhibitors, including preclinical drug candidates for previously undruggable proteins.
Explore ALLOX's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.